Ole Andreas Halvorsen
Viking Global Investors
Ole Andreas Halvorsen Syneos Health Inc stake
total: 670
Viking Global Investors SYNH trades
- Total transactions:
- 9
- New positions:
- 1
- Sold out:
- 1
- Added:
- 3
- Reduced:
- 4
- Held since:
- 2017 Q4
- Held for:
- 8 quarters
- Latest activity:
- 2019 Q4
According to 2026 Q2 report, Ole Andreas Halvorsen doesn't hold any Syneos Health Inc (SYNH) shares. To date, the estimated cost basis is nearly $44.04 for "buy" trades and estimated average "sell" price is $52.17. Viking Global Investors first purchased SYNH in 2017 Q4, initially acquiring about 1.56M shares. Since the initial investment in Syneos Health Inc (SYNH), Viking Global Investors has made 8 more transactions.
When did Ole Andreas Halvorsen sell Syneos Health Inc (SYNH)?
Ole Andreas Halvorsen sold off the entire Syneos Health Inc (SYNH) position in 2019 Q4.
When did Ole Andreas Halvorsen buy Syneos Health Inc (SYNH)?
Ole Andreas Halvorsen first invested in Syneos Health Inc (SYNH) in 2017 Q4 at the reported quarter-end price of $43.60 per share.
What's the cost basis of Viking Global Investors's SYNH stake?
The estimated cost basis for Syneos Health Inc (SYNH) stake is around $44.04 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $44.04
- Weighted AVG sell price:
- $52.17
Ole Andreas Halvorsen's historical trades in Syneos Health Inc
9 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2019 Q4
|
0.00%
|
$53.21
|
-100% (-575,847)
|
|||
|
2019 Q3
|
0.16%
|
$53.21
|
-67.95% (-1,220,928)
|
|||
|
2019 Q2
|
0.41%
|
$51.09
|
-19.03% (-422,299)
|
|||
|
2019 Q1
|
0.66%
|
$51.76
|
+26.35% (+462,724)
|
|||
|
2018 Q4
|
0.39%
|
$39.35
|
-2.65% (-47,754)
|
|||
|
2018 Q3
|
0.51%
|
$51.55
|
+1.77% (+31,323)
|
|||
|
2018 Q2
|
0.48%
|
$46.90
|
-7.93% (-152,767)
|
|||
|
2018 Q1
|
0.41%
|
$35.50
|
+23.55% (+367,036)
|
|||
|
2017 Q4
|
0.42%
|
$43.60
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.